Global and United States Escitalopram Oxalate API Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and United States Escitalopram Oxalate API Market Report & Forecast 2024-2034
Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. The mechanism of antidepressant action of escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
Escitalopram oxalate is an active pharmaceutical ingredient (API) used in the manufacturing of antidepressant medications. Escitalopram oxalate API is a fine white to off-white crystalline powder, which is soluble in water and typically used in tablet form.
Market Analysis and InsightsGlobal and United States Escitalopram Oxalate API Market
This report focuses on global and United States Escitalopram Oxalate API market, also covers the segmentation data of other regions in regional level and county level.
The global Escitalopram Oxalate API revenue was US$ 64 million in 2024 and is forecast to a readjusted size of US$ 103.4 million by 2034 with a CAGR of 6.9% during the forecast period (2024-2034).
Global key players of Escitalopram Oxalate API include Zhejiang Huahai, Dr. Reddy's, Shodhana Laboratories, Viatris, Aurobindo, etc. The top five players hold a share over 55%. Asia Pacific dominates the global Escitalopram Oxalate API market, with a share over 50% of the sales in value. In addition, Europe is also an important sales region. In terms of product type, both USDMF and COS/E-DMF is the largest segment, with a share about 90%. In terms of product application, the largest application is depression drug, with a share about 77%, followed by anxiety drug.
Global Escitalopram Oxalate API Scope and Market Size
Escitalopram Oxalate API market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Escitalopram Oxalate API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Escitalopram Oxalate API market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.
Sichuan Kelun
Zhejiang Huahai
Haisen Pharma
Viatris
Cipla
Aurobindo
Hetero Labs
Neuland
Smilax Laboratories
Jubilant Generics
Cadila Pharmaceuticals
Natco Pharma
Shodhana Laboratories
Dr. Reddy's
Segment by Type
Both USDMF and COS/E-DM
Only USDMF or COS/E-DM
Depression Drug
Anxiety Drug
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Escitalopram Oxalate API definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Escitalopram Oxalate API companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Escitalopram Oxalate API in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Escitalopram Oxalate API sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
Escitalopram oxalate is an active pharmaceutical ingredient (API) used in the manufacturing of antidepressant medications. Escitalopram oxalate API is a fine white to off-white crystalline powder, which is soluble in water and typically used in tablet form.
Market Analysis and InsightsGlobal and United States Escitalopram Oxalate API Market
This report focuses on global and United States Escitalopram Oxalate API market, also covers the segmentation data of other regions in regional level and county level.
The global Escitalopram Oxalate API revenue was US$ 64 million in 2024 and is forecast to a readjusted size of US$ 103.4 million by 2034 with a CAGR of 6.9% during the forecast period (2024-2034).
Global key players of Escitalopram Oxalate API include Zhejiang Huahai, Dr. Reddy's, Shodhana Laboratories, Viatris, Aurobindo, etc. The top five players hold a share over 55%. Asia Pacific dominates the global Escitalopram Oxalate API market, with a share over 50% of the sales in value. In addition, Europe is also an important sales region. In terms of product type, both USDMF and COS/E-DMF is the largest segment, with a share about 90%. In terms of product application, the largest application is depression drug, with a share about 77%, followed by anxiety drug.
Global Escitalopram Oxalate API Scope and Market Size
Escitalopram Oxalate API market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Escitalopram Oxalate API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Escitalopram Oxalate API market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.
By Company
Sichuan Kelun
Zhejiang Huahai
Haisen Pharma
Viatris
Cipla
Aurobindo
Hetero Labs
Neuland
Smilax Laboratories
Jubilant Generics
Cadila Pharmaceuticals
Natco Pharma
Shodhana Laboratories
Dr. Reddy's
Segment by Type
Both USDMF and COS/E-DM
Only USDMF or COS/E-DM
Segment by Application
Depression Drug
Anxiety Drug
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Escitalopram Oxalate API definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Escitalopram Oxalate API companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Escitalopram Oxalate API in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Escitalopram Oxalate API sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices